| Turkey | Thailand | South Korea | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from AUD $32,106 | from AUD $42,807 | from AUD $33,532 |
| Chemotherapy for breast cancer | from AUD $1,712 | from AUD $4,281 | from AUD $27,397 |
| Bladder removal | from AUD $11,415 | from AUD $17,123 | from AUD $26,398 |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $4,709 | from AUD $11,415 | from AUD $7,420 |
| Radiation therapy for colorectal cancer | from AUD $9,988 | from AUD $7,848 | - |
Professor Bulent Karagoz is a leading medical oncologist at Anadolu Medical Center, specialising in immunotherapy and targeted therapies for bladder cancer.
Professor Ilker Tinay is the Head of Uro-oncology at Anadolu Medical Center, a hospital affiliated with Johns Hopkins Medicine.
Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.
Dr Eda Tanrikulu is a senior medical oncologist at Anadolu Medical Center with a focus on targeted chemotherapy for urological cancers. She ranked 3rd nationwide in Turkey's prestigious medical specialty exams before joining this Johns Hopkins-affiliated facility.